Publications by authors named "X Janssens"
Objectives: This study aimed to (i) investigate actual work participation in Belgian spondyloarthritis (SpA) patients compared with the general population, and (ii) identify determinants of work-related outcomes.
Material And Methods: Adult SpA patients from the Ghent University Hospital based Be-GIANT cohort (fulfilling ASAS classification criteria) were cross-sectionally questioned on their socio-economic status and completed a Work Productivity and Activity Impairment questionnaire (May 2018 to May 2019). Results were compared with national and regional data on the general population using indirect standardization.
Article Synopsis
- Advanced biological therapies like adalimumab (ADM) are effective but expensive and can lose effectiveness over time; therapeutic drug monitoring (TDM) is suggested to optimize dosing, although it often takes a long time to get results.* -
- This study introduces a novel ADM-sensor that integrates fiber optic surface plasmon resonance (FO-SPR) and self-powered microfluidics, allowing for quick ADM monitoring directly in a doctor's office.* -
- The developed biosensor detects ADM in plasma with a limit of detection of 0.35 μg/mL and provides results in under 12 minutes, showcasing significant potential for bedside monitoring of various drugs beyond ADM in the future.*
Purpose: In this retrospective case series multicentric study, we assessed the efficiency and safety of micropulse transscleral cyclophotocoagulation (MP-TSCPC) among several types of advanced uncontrolled glaucoma cases. This study was intended to be a real-life study.
Methods: We treated 55 eyes with the Iridex Cyclo G6 device with the MP3 handpiece (IRIDEX Laser Systems) using a standardized protocol.
Objectives: To describe and explore differences in formal regulations around sick leave and work disability (WD) for patients with rheumatoid arthritis (RA), as well as perceptions by rheumatologists and patients on the system's performance, across European countries.
Methods: We conducted three cross-sectional surveys in 50 European countries: one on work (re-)integration and social security (SS) system arrangements in case of sick leave and long-term WD due to RA (one rheumatologist per country), and two among approximately 15 rheumatologists and 15 patients per country on perceptions regarding SS arrangements on work participation. Differences in regulations and perceptions were compared across categories defined by gross domestic product (GDP), type of social welfare regime, European Union (EU) membership and country RA WD rates.